Edap Tms (NASDAQ:EDAP) Stock Crosses Above 200-Day Moving Average - Here's What Happened

Key Points

• Edap Tms S.A. shares have crossed above their 200-day moving average, trading as high as $2.50, with the last price at $2.39.
• The company has a market capitalization of $89.36 million and a debt-to-equity ratio of just 0.04, suggesting a strong balance sheet.
• Over 62.74% of Edap Tms stock is currently owned by institutional investors and hedge funds, indicating significant investor interest.

Edap Tms S.A. (NASDAQ:EDAP - ) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $1.83 and traded as high as $2.50. Edap Tms shares last traded at $2.39, with a volume of 56,114 shares.

Edap Tms Trading Down 1.2%

The business has a fifty day moving average price of $1.89 and a two-hundred day moving average price of $1.83. The company has a current ratio of 1.51, a quick ratio of 1.05 and a debt-to-equity ratio of 0.04. The firm has a market capitalization of $89.36 million, a PE ratio of -3.92 and a beta of -0.21.

Hedge Funds Weigh In On Edap Tms

Several large investors have recently made changes to their positions in the stock. Sage Mountain Advisors LLC purchased a new position in shares of Edap Tms during the 2nd quarter worth approximately $165,000. Simplicity Wealth LLC acquired a new position in Edap Tms during the second quarter worth $54,000. Banque Transatlantique SA boosted its position in shares of Edap Tms by 7,063.7% during the first quarter. Banque Transatlantique SA now owns 730,699 shares of the medical equipment provider's stock worth $1,324,000 after buying an additional 720,499 shares during the period. Scoggin Management LP acquired a new stake in shares of Edap Tms in the first quarter valued at $686,000. Finally, Cetera Investment Advisers raised its holdings in shares of Edap Tms by 33.9% in the 1st quarter. Cetera Investment Advisers now owns 75,000 shares of the medical equipment provider's stock valued at $147,000 after buying an additional 19,000 shares during the period. 62.74% of the stock is currently owned by institutional investors and hedge funds.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.